TGFB1 and diabetic kidney disease: MiR-21 has been widely investigated because several of its targets that are relevant to DKD and especially related to TGF-β were found to induce the activation of phosphoinositide 3-kinase- (PI3K-) AKT signaling (Godwin et al., 2010; Zhong et al., 2011).